Rodrigo Antonini Ribeiro

Dr Ribeiro holds a degree in medicine, and a masters and PhD degree in epidemiology. He has been working with HTA in the last 15 years. In the last 7 years, he has acted as consultant to more than 20 pharmaceutical/medical devices companies in submissions for CMED (the pricing regulator in Brazil, inside ANVISA), CONITEC and ANS (the agencies responsible for public and private reimbursement, respectively). He is now CEO of HEMAP Consulting. In the academic field, he has published more than 60 papers, with an H factor of 25 in Google Scholar.